(NYSE: STE) Steris's forecast annual revenue growth rate of 6.39% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.22%.
Steris's revenue in 2026 is $6,037,600,000.On average, 13 Wall Street analysts forecast STE's revenue for 2027 to be $627,510,707,960, with the lowest STE revenue forecast at $606,450,684,200, and the highest STE revenue forecast at $654,420,738,320. On average, 13 Wall Street analysts forecast STE's revenue for 2028 to be $667,388,252,950, with the lowest STE revenue forecast at $638,040,719,840, and the highest STE revenue forecast at $698,685,788,260.
In 2029, STE is forecast to generate $709,605,800,580 in revenue, with the lowest revenue forecast at $683,963,271,650 and the highest revenue forecast at $742,658,337,870.